跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
邱 文祥
教授
醫學系泌尿學科
電話
(02)25553000#2000
電子郵件
whchiu1216
gmail
com
h-index
h10-index
h5-index
2969
引文
28
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
734
引文
14
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
155
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1990 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(193)
類似的個人檔案
(6)
指紋
查看啟用 Allen Wen-Hsiang Chiu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adrenal Tumor
17%
Adrenalectomy
28%
Bladder
62%
Bladder Cancer
27%
Bladder Neck Stenosis
24%
Bleeding
25%
Body Mass Index
15%
Cancer Specific Survival
14%
Clear Cell Renal Cell Carcinoma
18%
Cohort Analysis
16%
Computer Assisted Tomography
21%
Cystectomy
25%
Diseases
23%
Elderly Patient
16%
Hernioplasty
16%
Incision
32%
Kidney Stone
33%
Laparoscopic Surgery
68%
Ligation
29%
Lithotripsy
34%
Malignant Neoplasm
21%
Neoplasm
74%
Nephrectomy
24%
Nephroureterectomy
78%
Odds Ratio
22%
Operation Duration
30%
Overall Survival
14%
Partial Nephrectomy
36%
Pelvis
21%
Percutaneous Nephrolithotomy
22%
Peroperative Complication
14%
Pheochromocytoma
15%
Prevalence
14%
Prostate Cancer
24%
Prostate Hypertrophy
17%
Prostatectomy
22%
Recurrent Disease
19%
Retrospective Study
17%
Shock Wave
23%
Surgery
27%
Testes
19%
Thulium
18%
Transitional Cell Carcinoma
100%
Transurethral Resection
38%
Upper Urinary Tract
38%
Ureter
21%
Urinary Retention
17%
Urinary System
33%
Urinary Tract
17%
Urothelial Cancer
16%
Keyphrases
Arsenic
19%
Arsenic Exposure
16%
Benign Prostatic Hyperplasia
25%
Bladder Cancer
33%
Bladder Cuff Excision
18%
Bladder Neck Contracture
24%
Cancer-specific Survival
18%
Clinical Experience
23%
Clinical Outcomes
18%
Complication Rate
19%
Confidence Interval
32%
Decoy Receptor 3 (DcR3)
16%
Hand-assisted Retroperitoneoscopic Donor Nephrectomy
20%
Hepatoblastoma
16%
Insufflation
17%
Kidney
35%
Laparoscopic Adrenalectomy
18%
Laparoscopic Partial Nephrectomy
74%
Laparoscopic Surgery
35%
Laparoscopy
19%
Latanoprost
22%
Nephroureterectomy
40%
Oncological Outcomes
29%
Operative Time
33%
Partial Nephrectomy
17%
Percutaneous Nephrolithotomy
22%
Pneumoperitoneum
17%
Population-based Study
22%
Porcine Model
24%
Prostate
26%
Renal Cell Carcinoma
19%
Renal Tissue
17%
Retroperitoneoscopic
19%
Shock Wave Lithotripsy
18%
Single-center Experience
33%
Stone-free Rate
25%
Surgical Outcomes
19%
Taipei
64%
Taiwan
51%
Thulium Laser
17%
Transitional Cell Carcinoma
38%
Transurethral Resection of Prostate
33%
Tumor
42%
Tumor Size
17%
Upper Tract Urothelial Carcinoma
57%
Ureter
30%
Urinary Retention
17%
Urothelial Carcinoma
24%
Varicocele
20%
Younger Schoolchildren
17%
